NVCN 0.00 Neovasc Inc.
| Range: | 4.585-30.07 | Vol Avg: | 25784 | Last Div: | 0 | Changes: | 0 |
| Beta: | 2.01 | Cap: | 0.08B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed May 23 2001 | Empoloyees: | 49 | ||
| CUSIP: | 64065J304 | CIK: | 0001399708 | ISIN: | CA64065J3047 | Country: | CA |
| CEO: | Mr. Fredericus A. Colen | Website: | https://www.neovasc.com | ||||
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow